‘Proactive’ vaccine can protect against unknown future coronaviruses
Drug Discovery World
MAY 15, 2024
For example, the new vaccine does not include the SARS-CoV-1 coronavirus, which caused the 2003 SARS outbreak, yet it still induces an immune response to that virus. The vaccine should enter Phase I clinical trials in early 2025, but its complex nature makes it challenging to manufacture which could limit large-scale production.
Let's personalize your content